Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.

Satisfactory Completion
Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit of individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Society for Hematopathology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation Provider Number: 4008163

Physicians
ACCME Credit Designation Statement
Amedco LLC designates this live activity for a maximum of 16.75 AMA PRA Category 1 Credits^TM for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives - After Attending This Program You Should Be Able To

1. Provide practical recommendations in areas of diagnostic difficulty in T and NK cell neoplasms.
2. Identify advances in diagnostics, molecular pathogenesis and biomarkers.
3. Improve the understanding of the pathogenesis of T and NK cell neoplasms